ABVX Abivax Corp: Margin dodolan operasi

Simbol lan logo merek Abivax S.A. (ABVX)

ABIVAX is aggressively displacing injectable alternatives in the inflammatory bowel disease segment. The current operating margin on GURU.Markets contains the latest parameter 0.00, confirming the strategy's effectiveness. European laboratories ensure the production of immune agents through patent protection. High margins and a developed infrastructure enable the biotech company to compete successfully for technological leadership.

ABVX: Margin operasi Abivax SA 21.02.2024 - 19.11.2026

Rincian analitis lan laporan data perusahaan Abivax Corp (ABVX)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Ringkesan analisis perusahaan:Abivax SA
Produk dadi Abivax Pharma

Analyzing the operating margin of ABIVAX (ABVX), an investor can see the efficiency of drug development cost management before accounting for financial obligations and taxes. This indicator measures the proportion of core business profit relative to revenue, which, for a company with a compact R&D core, confirms a high return on intellectual capital and the resilience of the operating model when scaling clinical trials.

Pesaing wigati

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin operasi ADMA|Rasio bathi operasi PTGX|Rentabilitas operasi Immunovant Corp IMVT|Margin operasi Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Rentabilitas operasi|Rentabilitas kegiatan operasi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Margin dodolan operasi|Aurinia Pharmaceuticals Inc. (AUPH) - Margin operasi|Margin dodolan operasi BCRX|Rentabilitas dodolan operasi Vera Therapeutics Inc VERA|Margin dodolan operasi DNTH (Dianthus Pharma)|Rentabilitas kegiatan operasi Pharvaris N.V.|AbCellera Biologics Inc - Margin dodolan operasi|Tourmaline Bio (TRML) - Rentabilitas dodolan operasi|PGEN - Rentabilitas operasi|Tingkat bathi operasi PHAR (Pharming Group NV)|NKTR: Margin operasi|Upstream Bio Corp - Tingkat bathi operasi|Rentabilitas operasi Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com